Connection

Jason Cooper to Cyclooxygenase 2 Inhibitors

Back to Details
This is a "connection" page, showing publications Jason Cooper has written about Cyclooxygenase 2 Inhibitors.
Jason Cooper
Connection Strength
1.179
Cyclooxygenase 2 Inhibitors
  1. Authors' Reply to Urtasun et al.: "Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs". Am J Cardiovasc Drugs. 2017 12; 17(6):497-498.
    View in: PubMed
    Score: 0.593
  2. Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs. Am J Cardiovasc Drugs. 2017 Oct; 17(5):343-346.
    View in: PubMed
    Score: 0.586
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.